Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Catheter Precision (VTAK) EBT (2017 - 2025)

Catheter Precision has reported EBT over the past 9 years, most recently at -$6.1 million for Q4 2025.

  • Quarterly EBT fell 143.75% to -$6.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$19.5 million through Dec 2025, down 44.46% year-over-year, with the annual reading at -$19.5 million for FY2025, 44.46% down from the prior year.
  • EBT was -$6.1 million for Q4 2025 at Catheter Precision, down from -$2.3 million in the prior quarter.
  • Over five years, EBT peaked at -$669000.0 in Q4 2023 and troughed at -$66.4 million in Q1 2023.
  • The 5-year median for EBT is -$5.0 million (2021), against an average of -$7.9 million.
  • Year-over-year, EBT plummeted 1108.37% in 2023 and then soared 95.97% in 2024.
  • A 5-year view of EBT shows it stood at -$8.3 million in 2021, then grew by 1.53% to -$8.2 million in 2022, then surged by 91.8% to -$669000.0 in 2023, then crashed by 271.75% to -$2.5 million in 2024, then plummeted by 143.75% to -$6.1 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's EBT are -$6.1 million (Q4 2025), -$2.3 million (Q3 2025), and -$6.4 million (Q2 2025).